Dr Rajiv Modi's Cadila Pharmaceuticals Ltd. and Altus Formulation Inc. Announce New Flexitab Product Co-Development and Licensing Agreement

Media Coverages

Dr Rajiv Modi's Cadila Pharmaceuticals L...

18th October, 2017

Print Coverages

Nasdaq

18th Oct, 2017

Nasdaq

Baystreet

18th Oct, 2017

Baystreet

Privacy Policy ADR Reporting Drug Counterfeiting

Corporate Identification No : U24231GJ1991PLC015132

©2026 Cadila Pharmaceuticals. All rights reserved